Guard Therapeutics International AB (publ) announced that according to previous Annual General Meeting (AGM) resolutions, a Nomination Committee shall be appointed for the election and remuneration of the Board of Directors. The Nomination Committee shall consist of four members – one representative of each of the three largest shareholders who have accepted the assignment and the Chairman of the Board. The Nomination Committee has now been appointed and consists of the following members: Jan Ståhlberg, representing own holdings; Peter Wolpert, representing Stiftelsen Industrifonden; Marianne Nilsson, representing Swedbank Robur Fonder; and Johan Bygge, Chairman of the Board.